Charge Variant Analysis Global Market Report 2026

Charge variant analysis (CVA) is a method applied in biopharmaceutical development to detect and measure different charged forms of proteins or antibodies, which may result from post-translational modifications, degradation, or manufacturing processes. It ensures product consistency, stability, and effectiveness by tracking these charge variants throughout development and production.

The key techniques of charge variant analysis include ion exchange chromatography, capillary electrophoresis, isoelectric focusing, and others. Ion exchange chromatography is a separation method that isolates molecules based on their net electrical charge by using a charged stationary phase to attract oppositely charged ions. Product types include instruments, consumables, software, and services. Applications span biopharmaceuticals, research and development, quality control, and other areas, while end users include pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end-users.

Tariffs on imported analytical instruments, chromatography columns, and mass spectrometry equipment are impacting the charge variant analysis market by increasing procurement and operational costs, particularly affecting instruments, consumables, and software segments. Regions such as North America, Europe, and Asia-Pacific, which rely heavily on imported laboratory equipment, are most affected. While tariffs elevate costs, they also encourage domestic manufacturing, local sourcing of consumables, and innovation in cost-efficient analytical platforms, providing opportunities for regional supply chain development and self-reliance.

The charge variant analysis market research report is one of a series of new reports from The Business Research Company that provides charge variant analysis market statistics, including charge variant analysis industry global market size, regional shares, competitors with a charge variant analysis market share, detailed charge variant analysis market segments, market trends and opportunities, and any further data you may need to thrive in the charge variant analysis industry. This charge variant analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The charge variant analysis market size has grown strongly in recent years. It will grow from $1.15 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to growing biopharmaceutical production, rising need for protein characterization, adoption of chromatography-based analysis, increasing regulatory requirements for quality control, technological advancements in electrophoresis methods.

The charge variant analysis market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising demand for automated cva systems, growing adoption of ai-enabled data analysis, expansion of biologics and biosimilars market, increasing focus on real-time monitoring of protein variants, integration of high-throughput analytical platforms. Major trends in the forecast period include increasing adoption of capillary electrophoresis techniques, rising demand for high-throughput ion exchange chromatography, growing integration of cva software for data analysis, expansion of analytical services for biopharmaceutical qa/qc, rising focus on multi-product and platform development.

The expanding adoption of biosimilars is projected to drive the growth of the charge variant analysis market in the future. Biosimilars are biologic products highly similar to an already approved reference biologic in terms of safety, efficacy, and quality, though they may contain minor variations in clinically inactive components. The rising use of biosimilars is due to patent expirations on original biologic drugs, allowing manufacturers to produce lower-cost, clinically equivalent alternatives, which increases accessibility and market competition. Charge variant analysis supports biosimilars by verifying their structural and functional equivalence to the reference biologic, enabling accurate evaluation of product quality, stability, and therapeutic consistency. For example, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the number of FDA-approved biosimilar products in the U.S. rose from 33 in 2022, with 21 commercially available, to 40 in 2023, with 25 available on the market. Therefore, the growing use of biosimilars is driving the expansion of the charge variant analysis market.

Leading companies operating in the charge variant analysis market are increasingly focusing on developing innovative analytical solutions, such as advanced capillary isoelectric focusing-mass spectrometry (cIEF-MS) platforms, to enable faster, more precise, and high-resolution characterization of protein therapeutics. Capillary isoelectric focusing-mass spectrometry is an analytical technique that separates proteins based on their isoelectric point and subsequently identifies and characterizes charge variants using mass spectrometry, allowing detailed and accurate profiling of protein heterogeneity. For example, in June 2024, CMP Scientific Corp., a US-based biotechnology company, launched the BioSummit CVA System, an advanced cIEF-MS platform for online charge variant analysis. The system combines the company's proprietary EMASS II CE-MS coupling technology with CR3520 cIEF-MS chemistry and a novel time-of-flight mass spectrometer to deliver high sensitivity, robustness, and seamless analytical workflows tailored for recombinant protein characterization. It enables high-resolution separation and identification of charge variants in a single integrated run, features streamlined reagent workflows, enhanced operational robustness, and comprehensive data analysis software, making it suitable for biopharmaceutical research, quality control, and regulatory support applications.

In February 2026, CMP Scientific Corp., a US-based analytical technology company offering advanced, high-resolution charge variant analysis (CVA) solutions, partnered with Eurofins BPT China Laboratory to provide enhanced CE MS services for biopharmaceutical characterization. This partnership aims to improve charge variant analysis and overall protein therapeutic characterization by combining CMP Scientific's expertise in capillary electrophoresis-mass spectrometry (CE MS) workflows with Eurofins BPT China Laboratory's global analytical service capabilities. Eurofins BioPharma Product Testing (Shanghai) Co Ltd. is a China-based contract research organization specializing in analytical testing and biopharmaceutical development services.

Major companies operating in the charge variant analysis market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, SGS Societe Generale de Surveillance SA, Lonza Group AG, Agilent Technologies Inc., Creative Proteomics Inc., WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Sartorius AG, Shimadzu Corporation, Waters Corporation, Revvity Inc., Bio-Rad Laboratories Inc., Phenomenex Inc., Tosoh Bioscience LLC, JASCO Inc., Alturas Analytics Inc., BioPharmaSpec Inc., Eurofins Scientific SE.

North America was the largest region in the charge variant analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the charge variant analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the charge variant analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The charge variant analysis market consists of revenues earned by entities by providing services such as protein charge profiling, capillary isoelectric focusing (CIEF) analysis, mass spectrometry-based characterization, method development and validation, and stability and comparability studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The charge variant analysis market also includes sales of analytical instruments, consumables, technique specific platforms, workflow kits and method packages, hardware accessories, and chromatography consumables and accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Charge Variant Analysis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses charge variant analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for charge variant analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The charge variant analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Technique: Ion Exchange Chromatography; Capillary Electrophoresis; Isoelectric Focusing; Other Techniques
• 2) By Product Type: Instruments; Consumables; Software; Services
• 3) By Application: Biopharmaceuticals; Research And Development; Quality Control; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End-Users
• Subsegments:
• 1) By Ion Exchange Chromatography: Strong Cation Exchange; Weak Cation Exchange; Strong Anion Exchange; Weak Anion Exchange
• 2) By Capillary Electrophoresis: Capillary Zone Electrophoresis; Micellar Electrokinetic Chromatography; Capillary Gel Electrophoresis; Isoelectric Focusing Capillary Electrophoresis
• 3) By Isoelectric Focusing: Preparative Isoelectric Focusing; Analytical Isoelectric Focusing; Immobilized pH Gradient Isoelectric Focusing
• 4) By Other Techniques: High Performance Liquid Chromatography; Hydrophobic Interaction Chromatography; Affinity Chromatography; Mass Spectrometry Based Analysis
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; SGS Societe Generale de Surveillance SA; Lonza Group AG; Agilent Technologies Inc.; Creative Proteomics Inc.; WuXi AppTec Co Ltd.; Charles River Laboratories International Inc.; Sartorius AG; Shimadzu Corporation; Waters Corporation; Revvity Inc.; Bio-Rad Laboratories Inc.; Phenomenex Inc.; Tosoh Bioscience LLC; JASCO Inc.; Alturas Analytics Inc.; BioPharmaSpec Inc.; Eurofins Scientific SE.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.